Trelia J. Craft

The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies

Brian J. Eastwood, Mark W. Farmen, Philip W. Iversen et al. · SLAS DISCOVERY · 2006 · 122 citations · Full text

<i>N</i>²-Aroylanthranilamide Inhibitors of Human Factor Xa

Ying K. Yee, Anne Louise Tebbe, Jared H. Linebarger et al. · Journal of Medicinal Chemistry · 2000 · 48 citations

Molecular Pharmacology, Medicinal Chemistry, Drug Target +14

Structure-Based Design of Potent, Amidine-Derived Inhibitors of Factor Xa:  Evaluation of Selectivity, Anticoagulant Activity, and Antithrombotic Activity

Michael R. Wiley, Leonard C. Weir, Steven L. Briggs et al. · Journal of Medicinal Chemistry · 2000 · 46 citations

Drug Target, Pharmacotherapy, Amidine-derived Inhibitors +20

D-Phe-Pro-p-Amidinobenzylamine: A potent and highly selective thrombin inhibitor

Michael R. Wiley, Nickolay Y. Chirgadze, David K. Clawson et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 41 citations

Thrombosis, Medicinal Chemistry, Biochemistry +9

Non-Amidine-Containing 1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa with Potent Anticoagulant and Antithrombotic Activity

John J. Masters, Jeffry B. Franciskovich, Jennifer M. Tinsley et al. · Journal of Medicinal Chemistry · 2000 · 40 citations

Altmetric Attention Score, Pharmacotherapy, Translational Pharmacology +19